Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
This study has been completed.
Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
American Diabetes Association
Information provided by (Responsible Party):
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00362440
First received: August 9, 2006
Last updated: February 18, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |